Alkermes Total Assets 2006-2021 | ALKS

Alkermes total assets from 2006 to 2021. Total assets can be defined as the sum of all assets on a company's balance sheet.
Alkermes Annual Total Assets
(Millions of US $)
2020 $1,950
2019 $1,805
2018 $1,825
2017 $1,797
2016 $1,726
2015 $1,856
2014 $1,919
2013 $1,578
2013 $1,470
2012 $1,435
2011 $452
2010 $516
2009 $566
2008 $656
2007 $569
2006 $477
2005 $339
Alkermes Quarterly Total Assets
(Millions of US $)
2021-03-31 $1,878
2020-12-31 $1,950
2020-09-30 $1,877
2020-06-30 $1,802
2020-03-31 $1,826
2019-12-31 $1,805
2019-09-30 $1,758
2019-06-30 $1,752
2019-03-31 $1,757
2018-12-31 $1,825
2018-09-30 $1,761
2018-06-30 $1,751
2018-03-31 $1,737
2017-12-31 $1,797
2017-09-30 $1,748
2017-06-30 $1,731
2017-03-31 $1,730
2016-12-31 $1,726
2016-09-30 $1,707
2016-06-30 $1,785
2016-03-31 $1,795
2015-12-31 $1,856
2015-09-30 $1,881
2015-06-30 $1,915
2015-03-31 $1,925
2014-12-31 $1,919
2014-09-30 $1,838
2014-06-30 $1,858
2014-03-31 $1,835
2013-12-31 $1,578
2013-09-30 $1,512
2013-06-30 $1,478
2013-03-31 $1,470
2012-12-31 $1,412
2012-09-30 $1,371
2012-06-30 $1,446
2012-03-31 $1,435
2011-12-31 $1,506
2011-09-30 $1,504
2011-06-30 $451
2011-03-31 $452
2010-12-31 $447
2010-09-30 $449
2010-06-30 $492
2010-03-31 $516
2009-12-31 $520
2009-09-30 $527
2009-06-30 $535
2009-03-31 $566
2008-12-31 $597
2008-09-30 $605
2008-06-30 $649
2008-03-31 $656
2007-12-31 $730
2007-09-30 $573
2007-06-30 $564
2007-03-31 $569
2006-12-31 $563
2006-09-30 $544
2006-06-30 $558
2006-03-31 $477
2005-12-31 $483
2005-09-30 $489
2005-06-30 $487
2005-03-31 $339
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $4.026B $1.039B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $149.422B 10.36
Amgen (AMGN) United States $137.652B 14.85
CSL (CSLLY) Australia $105.792B 0.00
Gilead Sciences (GILD) United States $84.444B 8.99
Moderna (MRNA) United States $79.438B 158.27
Illumina (ILMN) United States $65.030B 93.77
Biogen (BIIB) United States $58.914B 13.48
Regeneron Pharmaceuticals (REGN) United States $55.784B 15.97
BioNTech SE (BNTX) Germany $49.234B 35.70
Vertex Pharmaceuticals (VRTX) United States $48.535B 19.99
Alexion Pharmaceuticals (ALXN) United States $39.905B 15.16
BeiGene (BGNE) Cayman Islands $30.669B 0.00
Genmab (GMAB) Denmark $29.247B 34.28
Seagen (SGEN) United States $27.461B 47.44
Genmab (GNMSF) Denmark $26.920B 6.19
Exact Sciences (EXAS) United States $20.651B 0.00
Horizon Therapeutics Public (HZNP) Ireland $20.431B 26.12
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $20.015B 0.00
Alnylam Pharmaceuticals (ALNY) United States $19.783B 0.00
Incyte (INCY) United States $18.280B 36.14
CureVac (CVAC) Germany $17.718B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.251B 41.91
Bio-Techne Corp (TECH) United States $17.211B 90.50
ARGENX SE-ADR (ARGX) Netherlands $16.043B 0.00
Zai Lab (ZLAB) China $15.466B 0.00
BioMarin Pharmaceutical (BMRN) United States $15.073B 137.47
Novavax (NVAX) United States $13.058B 0.00
Guardant Health (GH) United States $11.850B 0.00
QIAGEN (QGEN) Netherlands $10.950B 19.44
Repligen (RGEN) United States $10.440B 94.13
CRISPR Therapeutics AG (CRSP) Switzerland $9.389B 0.00
Denali Therapeutics (DNLI) United States $8.921B 320.04
Mirati Therapeutics (MRTX) United States $8.551B 0.00
Fate Therapeutics (FATE) United States $7.772B 0.00
Acceleron Pharma (XLRN) United States $7.693B 0.00
Ascendis Pharma (ASND) Denmark $7.196B 0.00
Exelixis (EXEL) United States $7.029B 112.15
Ultragenyx Pharmaceutical (RARE) United States $6.598B 0.00
Sarepta Therapeutics (SRPT) United States $6.553B 0.00
AbCellera Biologics (ABCL) $6.242B 0.00
Halozyme Therapeutics (HALO) United States $6.137B 33.67
Biohaven Pharmaceutical Holding (BHVN) United States $6.051B 0.00
Vir Biotechnology (VIR) United States $5.780B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.625B 20.38
Intellia Therapeutics (NTLA) United States $5.400B 0.00
Adaptive Biotechnologies (ADPT) United States $5.326B 0.00
Twist Bioscience (TWST) United States $5.230B 0.00
Beam Therapeutics (BEAM) United States $5.223B 0.00
Legend Biotech (LEGN) United States $5.178B 0.00
I-Mab (IMAB) China $5.177B 0.00
Reata Pharmaceuticals (RETA) United States $5.176B 0.00
NeoGenomics (NEO) United States $5.044B 855.40
Galapagos (GLPG) Belgium $4.995B 0.00
Blueprint Medicines (BPMC) United States $4.992B 15.20
Apellis Pharmaceuticals (APLS) United States $4.805B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.149B 0.00
Certara (CERT) United States $4.115B 0.00
Arvinas (ARVN) United States $4.018B 0.00
Arena Pharmaceuticals (ARNA) United States $3.923B 0.00
SpringWorks Therapeutics (SWTX) United States $3.908B 0.00
Intra-Cellular Therapies (ITCI) United States $3.492B 0.00
Emergent Biosolutions (EBS) United States $3.320B 6.61
Berkeley Lights (BLI) United States $3.115B 0.00
Insmed (INSM) United States $3.001B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.811B 0.00
Vericel (VCEL) United States $2.760B 744.25
Dicerna Pharmaceuticals (DRNA) United States $2.733B 0.00
Amicus Therapeutics (FOLD) United States $2.685B 0.00
MorphoSys AG (MOR) Germany $2.665B 0.00
Prothena (PRTA) Ireland $2.547B 0.00
Sorrento Therapeutics (SRNE) United States $2.501B 0.00
ALX Oncology Holdings (ALXO) United States $2.391B 0.00
Global Blood Therapeutics (GBT) United States $2.382B 0.00
Editas Medicine (EDIT) United States $2.374B 0.00
Morphic Holding (MORF) United States $2.346B 0.00
Myriad Genetics (MYGN) United States $2.321B 0.00
Heska (HSKA) United States $2.304B 1004.59
Instil Bio (TIL) United States $2.240B 0.00
Kymera Therapeutics (KYMR) United States $2.211B 0.00
Bluebird Bio (BLUE) United States $2.211B 0.00
Bionano Genomics (BNGO) United States $2.169B 0.00
Revance Therapeutics (RVNC) United States $2.151B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.143B 0.00
Ligand Pharmaceuticals (LGND) United States $2.085B 34.88
Seer (SEER) $1.957B 0.00
Atea Pharmaceuticals (AVIR) United States $1.943B 0.00
Amarin (AMRN) Ireland $1.930B 0.00
Myovant Sciences (MYOV) United Kingdom $1.927B 0.00
Protagonist Therapeutics (PTGX) United States $1.833B 0.00
Seres Therapeutics (MCRB) United States $1.810B 0.00
Castle Biosciences (CSTL) United States $1.807B 0.00
Inovio Pharmaceuticals (INO) United States $1.795B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.792B 0.00
Alector (ALEC) United States $1.789B 0.00
PHARMA MAR SA (PHMMF) Spain $1.777B 0.00
Zymeworks (ZYME) Canada $1.744B 0.00
Genetron Holdings (GTH) China $1.726B 0.00
Arcus Biosciences (RCUS) United States $1.704B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.658B 0.00
C4 Therapeutics (CCCC) United States $1.647B 0.00
REGENXBIO (RGNX) United States $1.628B 0.00
Sangamo Therapeutics (SGMO) United States $1.620B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.585B 0.00
UniQure (QURE) Netherlands $1.585B 0.00
Cytokinetics (CYTK) United States $1.563B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.559B 0.00
NGM Biopharmaceuticals (NGM) United States $1.506B 0.00
PureTech Health (PRTC) United States $1.506B 0.00
Avid Bioservices (CDMO) United States $1.478B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.446B 0.00
Nurix Therapeutics (NRIX) United States $1.365B 0.00
Precigen (PGEN) United States $1.354B 0.00
BioAtla (BCAB) United States $1.316B 0.00
Northwest Biotherapeutics (NWBO) United States $1.297B 0.00
Ocugen (OCGN) United States $1.290B 0.00
Codexis (CDXS) United States $1.282B 0.00
Zealand Pharma (ZEAL) Denmark $1.282B 0.00
MiMedx (MDXG) United States $1.274B 0.00
Keros Therapeutics (KROS) United States $1.235B 0.00
Repare Therapeutics (RPTX) Canada $1.231B 0.00
Shattuck Labs (STTK) United States $1.169B 0.00
KaloBios Pharmaceuticals (HGEN) United States $1.163B 0.00
Prometheus Biosciences (RXDX) United States $1.152B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.148B 0.00
Zealand Pharma (ZLDPF) Denmark $1.135B 0.00
Agenus (AGEN) United States $1.112B 0.00
Celldex Therapeutics (CLDX) United States $1.101B 0.00
Pliant Therapeutics (PLRX) United States $1.090B 0.00
Coherus BioSciences (CHRS) United States $1.087B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.083B 34.19
Scholar Rock Holding (SRRK) United States $1.079B 0.00
MannKind (MNKD) United States $1.079B 0.00
Mesoblast (MESO) Australia $1.060B 0.00
Dynavax Technologies (DVAX) United States $1.015B 0.00
Mersana Therapeutics (MRSN) United States $1.012B 0.00
VBI Vaccines (VBIV) United States $0.999B 0.00
Avidity Biosciences (RNA) United States $0.981B 0.00
Inhibrx (INBX) United States $0.937B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.920B 0.00
G1 THERAPEUTICS (GTHX) United States $0.914B 0.00
Travere Therapeutics (TVTX) United States $0.909B 0.00
Epizyme (EPZM) United States $0.900B 0.00
Cel-Sci (CVM) United States $0.881B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.865B 0.00
Nkarta (NKTX) United States $0.861B 0.00
Sutro Biopharma (STRO) United States $0.844B 0.00
Merus (MRUS) Netherlands $0.803B 0.00
Affimed (AFMD) Germany $0.802B 0.00
Verastem (VSTM) United States $0.801B 0.00
RAPT THERAPTICS (RAPT) United States $0.800B 0.00
Pharming Group (PHAR) Netherlands $0.761B 0.00
Pharming Group (PHGUF) Netherlands $0.751B 20.00
SESEN BIO, INC (SESN) United States $0.738B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.736B 0.00
Cara Therapeutics (CARA) United States $0.728B 63.26
IDEAYA Biosciences (IDYA) United States $0.722B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.715B 0.00
Kadmon Holdings (KDMN) United States $0.698B 0.00
Curis (CRIS) United States $0.694B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.692B 0.00
DBV Technologies S.A (DBVT) France $0.685B 0.00
AnaptysBio (ANAB) United States $0.683B 0.00
MeiraGTx Holdings (MGTX) United States $0.678B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.674B 0.00
Clene (CLNN) United States $0.670B 0.00
Cellectis S.A (CLLS) France $0.669B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.665B 0.00
ChromaDex (CDXC) United States $0.664B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
ALBIREO PHARMA (ALBO) United States $0.637B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.627B 0.00
Clovis Oncology (CLVS) United States $0.618B 0.00
Precision BioSciences (DTIL) United States $0.609B 0.00
Anika Therapeutics (ANIK) United States $0.604B 0.00
Adagene (ADAG) China $0.603B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.597B 0.00
Bolt Biotherapeutics (BOLT) United States $0.596B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.593B 0.00
Inventiva S.A (IVA) France $0.587B 0.00
Selecta Biosciences (SELB) United States $0.554B 0.00
Codiak BioSciences (CDAK) United States $0.552B 0.00
AC Immune SA (ACIU) Switzerland $0.538B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.521B 0.00
Compugen (CGEN) Israel $0.520B 0.00
Forte Biosciences (FBRX) United States $0.518B 0.00
Starpharma Holdings (SPHRY) Australia $0.506B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.492B 0.00
XBiotech (XBIT) United States $0.487B 0.00
Gritstone Bio (GRTS) United States $0.477B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.464B 0.00
CytomX Therapeutics (CTMX) United States $0.464B 0.00
Oncobiologics (OTLK) United States $0.451B 0.00
Opthea (OPT) Australia $0.450B 0.00
Geron (GERN) United States $0.449B 0.00
Athenex (ATNX) United States $0.448B 0.00
Spero Therapeutics (SPRO) United States $0.441B 0.00
BeyondSpring (BYSI) United States $0.433B 0.00
Neoleukin Therapeutics (NLTX) United States $0.426B 0.00
Amryt Pharma (AMYT) United Kingdom $0.423B 0.00
ANI Pharmaceuticals (ANIP) United States $0.423B 11.67
Paratek Pharmaceuticals (PRTK) United States $0.422B 0.00
Kindred Biosciences (KIN) United States $0.418B 0.00
Puma Biotechnology (PBYI) United States $0.417B 0.00
AquaBounty Technologies (AQB) United States $0.413B 0.00
Cue Biopharma (CUE) United States $0.411B 0.00
Angion Biomedica (ANGN) United States $0.393B 0.00
Kala Pharmaceuticals (KALA) United States $0.378B 0.00
SQZ Biotechnologies (SQZ) United States $0.371B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.362B 0.00
UROGEN PHARMA (URGN) United States $0.360B 0.00
Adverum Biotechnologies (ADVM) United States $0.357B 0.00
Cogent Biosciences (COGT) United States $0.353B 0.00
WAVE Life Sciences (WVE) Singapore $0.352B 0.00
BioDelivery Sciences (BDSI) United States $0.351B 14.24
Syros Pharmaceuticals (SYRS) United States $0.348B 0.00
Fortress Biotech (FBIO) United States $0.346B 0.00
XOMA (XOMA) United States $0.345B 161.26
Athersys (ATHX) United States $0.342B 0.00
Frequency Therapeutics (FREQ) United States $0.341B 0.00
Theratechnologies (THTX) Canada $0.340B 0.00
Prima BioMed (IMMP) Australia $0.339B 0.00
IBio (IBIO) United States $0.338B 0.00
Cerecor (CERC) United States $0.337B 0.00
Adicet Bio (ACET) United States $0.331B 0.00
Trevena (TRVN) United States $0.327B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.322B 0.00
Innate Pharma S.A (IPHA) France $0.311B 0.00
Arbutus Biopharma (ABUS) United States $0.310B 0.00
CorMedix Inc (CRMD) United States $0.310B 0.00
OVID THERAPEUTC (OVID) United States $0.300B 2.95
Cardiff Oncology (CRDF) United States $0.300B 0.00
PDL BioPharma (PDLI) United States $0.283B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.279B 0.00
Fulcrum Therapeutics (FULC) United States $0.276B 0.00
Kaleido Biosciences (KLDO) $0.273B 0.00
INmune Bio (INMB) United States $0.266B 0.00
Talis Biomedical (TLIS) United States $0.266B 0.00
Bellus Health (BLU) Canada $0.266B 0.00
Kamada (KMDA) Israel $0.257B 17.49
Seelos Therapeutics (SEEL) United States $0.251B 0.00
HOOKIPA Pharma (HOOK) United States $0.249B 0.00
Chiasma (CHMA) United States $0.240B 0.00
Clearside Biomedical (CLSD) United States $0.235B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.235B 0.00
ADMA Biologics Inc (ADMA) United States $0.231B 0.00
Aptinyx (APTX) United States $0.229B 0.00
NextCure (NXTC) United States $0.227B 0.00
Checkpoint Therapeutics (CKPT) United States $0.220B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.220B 0.00
Synlogic (SYBX) United States $0.215B 0.00
VTv Therapeutics (VTVT) United States $0.202B 0.00
TELA Bio (TELA) United States $0.201B 0.00
POXEL SA FRANCE (PXXLF) France $0.197B 0.00
Strongbridge Biopharma (SBBP) United States $0.195B 0.00
Biofrontera AG (BFRA) Germany $0.193B 0.00
X4 Pharmaceuticals (XFOR) United States $0.189B 0.00
Applied Genetic Technologies (AGTC) United States $0.186B 0.00
OSMOTICA PHARM (OSMT) United States $0.184B 0.00
GENFIT S.A (GNFT) France $0.183B 0.00
Voyager Therapeutics (VYGR) United States $0.182B 4.68
VolitionRX (VNRX) United States $0.180B 0.00
PHASEBIO PHARMA (PHAS) United States $0.179B 0.00
ObsEva SA (OBSV) Switzerland $0.172B 0.00
Galena Biopharma (SLS) United States $0.172B 0.00
Abeona Therapeutics (ABEO) United States $0.171B 0.00
Nicox SA (NICXF) France $0.171B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.163B 0.00
Eton Pharmaceuticals (ETON) United States $0.158B 0.00
Antibe Therapeutics (ATBPF) Canada $0.156B 0.00
DiaMedica Therapeutics (DMAC) United States $0.151B 0.00
Exicure (XCUR) United States $0.146B 0.00
Enzo Biochem (ENZ) United States $0.145B 42.86
Eyenovia (EYEN) United States $0.138B 0.00
Liquidia Technologies (LQDA) United States $0.138B 0.00
LogicBio Therapeutics (LOGC) United States $0.137B 0.00
Novogen (KZIA) Australia $0.136B 0.00
Catalyst Biosciences (CBIO) United States $0.136B 0.00
Yumanity Therapeutics (YMTX) United States $0.135B 0.00
Erytech Pharma SA (ERYP) France $0.133B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.133B 0.00
Aptevo Therapeutics (APVO) United States $0.131B 0.00
Longeveron (LGVN) United States $0.130B 0.00
Palatin Technologies (PTN) United States $0.130B 0.00
Cyclerion Therapeutics (CYCN) United States $0.129B 0.00
Pluristem Therapeutics (PSTI) Israel $0.128B 0.00
Aytu BioPharma (AYTU) United States $0.128B 0.00
ABVC BioPharma (ABVC) United States $0.127B 0.00
Cocrystal Pharma (COCP) United States $0.127B 0.00
Liminal BioSciences (LMNL) Canada $0.125B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.124B 0.00
Orgenesis (ORGS) United States $0.121B 246.50
Beyond Air (XAIR) United States $0.116B 0.00
Celsion (CLSN) United States $0.114B 0.00
Vyant Bio (VYNT) United States $0.114B 0.00
Evofem Biosciences (EVFM) United States $0.114B 0.00
Vascular Biogenics (VBLT) Israel $0.110B 0.00
CytRx (CYTR) United States $0.107B 0.00
ARAVIVE, INC (ARAV) United States $0.106B 0.00
Armata Pharmaceuticals (ARMP) United States $0.105B 0.00
Zosano Pharma (ZSAN) United States $0.104B 0.00
Leap Therapeutics (LPTX) United States $0.102B 0.00
Cidara Therapeutics (CDTX) United States $0.100B 0.00
TRACON Pharmaceuticals (TCON) United States $0.099B 0.00
Entera Bio (ENTX) Israel $0.099B 0.00
Dyadic (DYAI) United States $0.095B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.093B 0.00
Protalix BioTherapeutics (PLX) Israel $0.092B 0.00
Evogene (EVGN) Israel $0.092B 0.00
Lumos Pharma (LUMO) United States $0.091B 0.00
AIkido Pharma (AIKI) United States $0.090B 0.00
Purple Biotech (PPBT) Israel $0.089B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.087B 0.00
BioCardia (BCDA) United States $0.084B 0.00
Emmaus Life Sciences (EMMA) United States $0.079B 0.00
Cleveland BioLabs (CBLI) United States $0.078B 0.00
ATyr Pharma (LIFE) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
ARIDIS PHARMACT (ARDS) United States $0.077B 0.00
Celyad SA (CYAD) Belgium $0.076B 0.00
Edesa Biotech (EDSA) Canada $0.074B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Viridian Therapeutics (VRDN) United States $0.073B 0.00
Advaxis (ADXS) United States $0.071B 0.00
Alimera Sciences (ALIM) United States $0.069B 0.00
Cyclo Therapeutics (CYTH) United States $0.065B 0.00
Genetic Technologies (GENE) Australia $0.062B 0.00
Idera Pharmaceuticals (IDRA) United States $0.062B 0.00
Organovo Holdings (ONVO) United States $0.061B 0.00
Windtree Therapeutics (WINT) United States $0.061B 0.00
Pulmatrix (PULM) United States $0.060B 0.00
AEterna Zentaris (AEZS) United States $0.059B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.059B 0.00
Enzon Pharmaceuticals (ENZN) United States $0.052B 0.00
AnPac Bio-Medical Science (ANPC) China $0.052B 0.00
Soligenix (SNGX) United States $0.048B 0.00
Enveric Biosciences (ENVB) United States $0.048B 0.00
Timber Pharmaceuticals (TMBR) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.046B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
Acorda Therapeutics (ACOR) United States $0.039B 0.94
GeoVax Labs (GOVX) United States $0.034B 0.00
ThermoGenesis Holdings (THMO) United States $0.034B 0.00
Benitec Biopharma (BNTC) United States $0.034B 0.00
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.033B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.032B 0.00
Prana Biotechnology (ATHE) Australia $0.032B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.025B 0.00
ZIVO Bioscience (ZIVO) United States $0.024B 0.00
Palisade Bio (PALI) United States $0.012B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) United States $0.000B 0.00